I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| fibroblast | 3 studies | 17% ± 1% | |
| GABAergic neuron | 3 studies | 27% ± 3% | |
| glutamatergic neuron | 3 studies | 30% ± 2% | |
| astrocyte | 3 studies | 32% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| fibroblast | 3 studies | 17% ± 1% | |
| GABAergic neuron | 3 studies | 27% ± 3% | |
| glutamatergic neuron | 3 studies | 30% ± 2% | |
| astrocyte | 3 studies | 32% ± 15% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 100% | 934.25 | 459 / 459 | 100% | 19.11 | 1118 / 1118 |
| esophagus | 100% | 591.56 | 1445 / 1445 | 100% | 14.13 | 183 / 183 |
| intestine | 100% | 603.91 | 966 / 966 | 100% | 16.99 | 527 / 527 |
| ovary | 100% | 885.06 | 180 / 180 | 100% | 17.26 | 430 / 430 |
| prostate | 100% | 807.67 | 245 / 245 | 100% | 19.09 | 502 / 502 |
| stomach | 100% | 589.71 | 359 / 359 | 100% | 14.75 | 286 / 286 |
| bladder | 100% | 756.76 | 21 / 21 | 100% | 15.05 | 503 / 504 |
| uterus | 100% | 799.83 | 170 / 170 | 100% | 14.72 | 458 / 459 |
| pancreas | 100% | 668.34 | 327 / 328 | 100% | 12.12 | 178 / 178 |
| lung | 100% | 706.85 | 577 / 578 | 100% | 13.41 | 1153 / 1155 |
| thymus | 100% | 785.44 | 653 / 653 | 100% | 13.63 | 602 / 605 |
| kidney | 100% | 797.06 | 89 / 89 | 98% | 15.70 | 882 / 901 |
| skin | 100% | 859.21 | 1809 / 1809 | 98% | 14.35 | 461 / 472 |
| liver | 100% | 388.63 | 225 / 226 | 98% | 9.69 | 397 / 406 |
| brain | 97% | 326.46 | 2550 / 2642 | 98% | 9.83 | 694 / 705 |
| adrenal gland | 100% | 1142.80 | 258 / 258 | 87% | 6.71 | 200 / 230 |
| adipose | 100% | 973.12 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 795.93 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 11.07 | 29 / 29 |
| spleen | 100% | 404.84 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 13.62 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.61 | 1 / 1 |
| muscle | 100% | 482.75 | 800 / 803 | 0% | 0 | 0 / 0 |
| heart | 96% | 532.05 | 829 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 93% | 8.94 | 74 / 80 |
| peripheral blood | 59% | 353.33 | 552 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0001570 | Biological process | vasculogenesis |
| GO_0006418 | Biological process | tRNA aminoacylation for protein translation |
| GO_0045766 | Biological process | positive regulation of angiogenesis |
| GO_0070183 | Biological process | mitochondrial tryptophanyl-tRNA aminoacylation |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005759 | Cellular component | mitochondrial matrix |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0004830 | Molecular function | tryptophan-tRNA ligase activity |
| GO_0005524 | Molecular function | ATP binding |
| Gene name | WARS2 |
| Protein name | Tryptophan--tRNA ligase, mitochondrial (EC 6.1.1.2) ((Mt)TrpRS) (Tryptophanyl-tRNA synthetase) (TrpRS) |
| Synonyms | |
| Description | FUNCTION: Catalyzes the attachment of tryptophan to tRNA(Trp) in a two-step reaction: tryptophan is first activated by ATP to form Trp-AMP and then transferred to the acceptor end of tRNA(Trp). . |
| Accessions | Q9UGM6 ENST00000235521.5 [Q9UGM6-1] ENST00000369426.9 [Q9UGM6-2] |
